• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Catalog Number 7510800
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Dyspnea (1816); Fever (1858); Pain (1994); Fibrosis (3167)
Event Type  Injury  
Manufacturer Narrative
(b)(6).(b)(4).Neither device nor applicable imaging studies returned to manufacturer for evaluation.
 
Event Description
(b)(6) 2007: the patient presented with severe pain in her back.The patient underwent the following procedures: 1.Removal of instrumentation of lumbar spine.2.Exploration of fusion mass.3.Supplementation of fusion mass/fusion l2 to l5 with rh-bmp2/acs.Per op note, this was done in standard fashion by using rh-bmp2/acs on a collagen sponge wrapping it around the graft matrix and after decorticating the fusion mass applying the composite graft from l2 to l5 in the fusion mass area.No patient complications were reported.(b)(6) 2007: the patient underwent portable chest due to post-op fever and shortness of breath.Impression: fibrotic stranding in both lungs, stable.(b)(6) 2015: the patient presented for a follow up office visit.Ap, flexion/extension lateral x-rays of the lumbar spine demonstrates what appears to be a solid fusion.No obvious loosening of her construct seen, no obvious motion on flexion/extension views.She has stable mild degenerative changes at 5-1.(b)(6) 2007: the patient presented for a follow up office visit.(b)(6) 2007: the patient presented for a follow up office visit.Ap, flexion-extension lateral x-rays of the lumbar spine me reviewed.There is no evidence to suggest any sort of instability or movement.X-ray of her pelvis are unremarkable.(b)(6) 2007: the patient underwent nm bone scan due to complications related to internal orthopedic device.Conclusion: total body bone scintigraphy demonstrates increased tracer uptake within the axial and appendicular skeleton as noted above.(b)(6) 2007: the patient underwent open mri lumbar spine w <(>&<)> w/o contrast due to back pain.Conclusion: mr imaging of the lumbar spine demonstrates extensive postoperative changes.There is no evidence of recurrent herniated nucleus pulposus.There is epidural fibrosis (scarring).(b)(6) 2007: the patient presented for a follow up office visit.Her mri is reviewed she has some epidural fibrosis noted at the 2-3 mid 4-5 levels.Otherwise i don't see any significant pathology, her bone scan is unremarkable.It shows some increased uptake in the areas of her previous surgery.(b)(6) 2007: the patient presented for a follow up office visit.(b)(6) 2007: the patient underwent open mri of lumbar spine with and without contrast due to lumbago.Impression: extensive post-surgical changes identified with transpedicular screws at multiple levels, as above.Disc space narrowing is most prominent at l2-3 and l4-5.No significant interval change is convincingly demonstrated when compared to the prior mri examination from late (b)(6) 2007.Continued clinical correlation with regard to current clinical presentation is recommended.(b)(6) 2007: the patient presented for a follow up office visit.The mri impression shows extensive postsurgical changes identified with transpedicular screws at multiple levels.Disc space narrowing is most prominent at l2-3 and l4-) no significant interval change was convincingly demonstrated when compared to the prim mri examination from late (b)(6) 2007.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK
1800 pyramid place
memphis TN 38132
Manufacturer Contact
greg anglin
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key5064127
MDR Text Key25272115
Report Number1030489-2015-02258
Device Sequence Number1
Product Code NEK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Attorney
Report Date 08/11/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/01/2009
Device Catalogue Number7510800
Device Lot NumberM110606AAE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/09/2015
Was Device Evaluated by Manufacturer? No
Date Device Manufactured02/20/2007
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Weight80
-
-